Rapafusyn Pharmaceuticals raised $28M Series A venture round, led by Karen Liu.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
Proxima VenturesLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$72M
Top Valuation
-
Rapafusyn Pharmaceuticals raised $28M in a Series A round.
The round was announced on 06/24/24.
The round was led by Karen Liu, Proxima Ventures.